filmov
tv
PARP Combinations: The Future
Показать описание
A brief discussion on potential combinations of poly ADP ribose polymerase (PARP) inhibitors and immunotherapy agents for the treatment of advanced ovarian cancer.
OncLive
cancer
oncology
Рекомендации по теме
0:04:49
PARP Combinations: The Future
0:01:58
PARP Inhibitor Combinations and Future of Ovarian Cancer
0:06:25
Combinations With PARP Inhibitors for Ovarian Cancer
0:18:37
Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer
0:04:59
Future Role of PARP Inhibition in BRCA+ Breast Cancer
0:09:51
PARP in Combination with Standard of Care Treatment
0:00:49
Combinations May Combat PARP Resistance
0:35:38
PARP Inhibitor Combination Regimens for Prostate Cancer Management
0:00:45
Evaluating future use of PARP inhibitors in neoadjuvant therapy for ovarian cancer
0:12:24
The Role of Targeting DNA Repair with PARP
0:54:40
PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry Genetics
0:59:14
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
0:03:34
Future of PARP Inhibitors in mCRPC
0:15:23
Future possibilities of PARP-inhibition in the case of disturbance of homologous recombination
0:01:40
Dr. Moore on Immunotherapy and PARP Combinations in BRCA-Mutated Ovarian Cancer
2:48:58
Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combination...
0:02:14
JAVELIN PARP Medley: Combining PARP inhibitors and immune checkpoint inhibitors
0:17:53
Role of Immunotherapy and PARP Inhibitors
0:02:20
Future of PARP inhibitors for urothelial carcinoma
0:00:52
Dr. Morgan on Combinations With PARP Inhibitors in Prostate Cancer
0:01:21
Looking to the Future of PARP Inhibitors in CRPC
0:01:11
Dr. Backes Discusses PARP Inhibitor Combinations in Ovarian Cancer
0:02:04
Questions That Remain Regarding Combination, Sequencing With PARP Inhibitors
0:01:14
Dr. O'Malley Discusses PARP Combinations in Ovarian Cancer